<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Deregulated miRNAs participate in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, miR-218 was found to be downregulated in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) by miRNA profile assay </plain></SENT>
<SENT sid="2" pm="."><plain>miR-218 was silenced or downregulated in <z:hpo ids='HP_0000001'>all</z:hpo> five <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells (Caco2, HT29, SW620, HCT116 and LoVo) relative to <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissues </plain></SENT>
<SENT sid="3" pm="."><plain>miR-218 expression was significantly lower in 46 CRC <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues compared with their adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Potential target genes of miR-218 were predicted and BMI1 polycomb ring finger oncogene (BMI-1), a polycomb ring finger oncogene, was identified as one of the potential targets </plain></SENT>
<SENT sid="5" pm="."><plain>Upregulation of BMI-1 was detected in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> compared with adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (P &lt; 0.001) and in <z:hpo ids='HP_0000001'>all</z:hpo> five <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
<SENT sid="6" pm="."><plain>Transfection of miR-218 in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines (HCT116, HT29) significantly reduced luciferase activity of the <z:mp ids='MP_0002169'>wild-type</z:mp> construct of BMI-1 3' untranslated region (3'UTR) (P &lt; 0.001), whereas this effect was not seen in the construct with mutant BMI-1 3'UTR, indicating a direct and specific interaction of miR-218 with BMI-1 </plain></SENT>
<SENT sid="7" pm="."><plain>Ectopic expression of miR-218 in HCT116 and HT29 cells suppressed BMI-1 mRNA and protein expression </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, miR-218 suppressed protein expression of BMI-1 downstream targets of cyclin-dependent kinase 4, a cell cycle regulator, while upregulating protein expression of p53 </plain></SENT>
<SENT sid="9" pm="."><plain>We further revealed that miR-218 induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (P &lt; 0.01), inhibited cell proliferation (P &lt; 0.05) and promoted cell cycle arrest in the G2 phase (P &lt; 0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, miR-218 plays a pivotal role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development through inhibiting cell proliferation and cycle progression and promoting <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by downregulating BMI-1 </plain></SENT>
</text></document>